Skip to content
PIL Logo

MOVIPREP, powder for oral solution

Last Updated on eMC 06-Feb-2017 View document  | Norgine Limited Contact details

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC.  For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 06-Feb-2017 and displayed until Current

Reasons for adding or updating:

  • Change to section 4 - how to report a side effect
  • Change to section 6 - date of revision

Updated on 06-Jul-2016 and displayed until 06-Feb-2017

Reasons for adding or updating:

  • Change to section 2 - excipient warnings
  • Correction of spelling/typing errors

Updated on 07-Aug-2015 and displayed until 06-Jul-2016

Reasons for adding or updating:

  • Change to section 2 - what you need to know - contraindications
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 2 - pregnancy, breast feeding and fertility
  • Change to section 3 - dose and frequency
  • Change to section 3 - how to take/use
  • Change to section 3 - overdose, missed or forgotten doses
  • Change to section 4 - possible side effects
  • Change to section 5 - how to store
  • Change to section 6 - what the product looks like and pack contents
  • Change to section 6 - date of revision
  • Correction of spelling/typing errors
  • Improved presentation of PIL

Updated on 05-Jul-2013 and displayed until 07-Aug-2015

Reasons for adding or updating:

  • Improved presentation of PIL

Updated on 18-Jan-2013 and displayed until 05-Jul-2013

Reasons for adding or updating:

  • Change to section 4 - possible side effects

Updated on 14-Nov-2011 and displayed until 18-Jan-2013

Reasons for adding or updating:

  • Change of trade or generic name
  • Change to date of revision
  • Extra statutory information

Updated on 26-Apr-2007 and displayed until 14-Nov-2011

Reasons for adding or updating:

  • Improved Electronic Presentation

Updated on 05-Feb-2007 and displayed until 26-Apr-2007

Reasons for adding or updating:

  • New PIL for new product

Company contact details

Norgine Limited

Company image
Address

Norgine House, Widewater Place, Moorhall Road, Harefield, Middlesex, UB9 6NS

Fax

+44 (0)1895 825 865

Medical Information e-mail
Telephone

+44 (0)1895 826 600

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Active ingredients

ascorbic acid, macrogol 3350, potassium chloride, sodium ascorbate, sodium chloride, sodium sulfate, anhydrous

Legal categories

P - Pharmacy

This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue